Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  pan-PI3K/mTOR inhibitor SF1126
Find trials that include:  Any drugs shown
Results 1-2 of 2 for your search:
Start Over
A Study of Single Agent SF1126 Inhibitor in Patients With Advanced Hepatocellular Carcinoma
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 161077, NCI-2017-01453, FD-05113, NCT03059147
Start Over